Stock Earnings

Question 1

TriSalus Life Sciences Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、TriSalus Life Sciences Incの総資産は$24で、純lossは$-33です。

Question 2

TLSIの主要な財務比率は何ですか？

Accepted Answer

TriSalus Life Sciences Incの流動比率は0.48、純利益率は-113.79、1株当たり売上高は$1.16です。

Question 3

TriSalus Life Sciences Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

TriSalus Life Sciences Inc largest revenue segment is Innovative Drug Delivery Technology and Immune-oncology Therapeutics, at a revenue of 18,511,000 in the most earnings release.For geography, United States is the primary market for TriSalus Life Sciences Inc, at a revenue of 18,511,000.

Question 4

TriSalus Life Sciences Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、TriSalus Life Sciences Incの純lossは$-33です。

Question 5

TriSalus Life Sciences Incに負債はありますか？

Accepted Answer

yes、TriSalus Life Sciences Incの負債は50です。

Question 6

TriSalus Life Sciences Incの発行済株式数は何株ですか？

Accepted Answer

TriSalus Life Sciences Incの総発行済株式数は31株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	35	29	18	0	0	0
Revenue Growth (YoY)	13%	61%	--	--	--	--
Cost of Revenue	5	4	2	--	--	--
Gross Profit	30	25	15	--	--	--
Selling, General & Admin	48	44	41	2	3	0
Research & Development	14	17	29	--	--	--
Operating Expenses	61	61	70	2	3	0
Other Non Operating Income (Expenses)	4	8	0	5	7	0
Pretax Income	-30	-30	-59	6	4	0
Income Tax Expense	0	0	0	0	--	--
Net Income	-34	-33	-64	5	4	0
Net Income Growth	-40%	-48%	-1,380%	25%	--	--
Shares Outstanding (Diluted)	33	25	9.4	29.61	31.25	30.56
Shares Change (YoY)	38%	166%	-68%	-5%	2%	--
EPS (Diluted)	-1.03	-1.31	-6.8	0.19	0.15	-0.02
EPS Growth	-56.99%	-81%	-3,679%	27%	-850%	--
Free Cash Flow	-29	-41	-51	-2	-1	0
Free Cash Flow Per Share	-0.87	-1.64	-5.42	-0.06	-0.03	0
Gross Margin	85.71%	86.2%	83.33%	--	--	--
Operating Margin	-85.71%	-124.13%	-300%	0%	0%	0%
Profit Margin	-97.14%	-113.79%	-355.55%	0%	0%	0%
Free Cash Flow Margin	-82.85%	-141.37%	-283.33%	0%	0%	0%
EBITDA	-30	-36	-54	--	--	--
EBITDA Margin	-85.71%	-124.13%	-300%	--	--	--
D&A For EBITDA	0	0	0	--	--	--
EBIT	-30	-36	-54	-2	-3	0
EBIT Margin	-85.71%	-124.13%	-300%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	--	--

TriSalus Life Sciences Inc (TLSI) Price

TLSI Stock Price Chart

TLSI Income

Follow-Up Questions